SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

ex-RPS CIO drops wrongful dismissal lawsuit and allegations the CRO unlawfully stored applicant data

Former RPS staffer settles lawsuit

An ex RPS employee who claimed he was sacked after discovering the CRO was unlawfully storing potential employees’ personal data has settled his lawsuit and withdrawn allegations of wrongdoing.

Related news

News in brief

Australia’s largest clinical CRO Novotech has expanded its services into China with a new office in Shanghai.

Evotec has announced positive milestone news this week, revealing that efforts to develop an endometriosis drug with Bayer have moved into preclinical testing.

In a sign of further industry consolidation, CRO Chiltern has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. Financial terms were not announced.

Consort Medical will buy UK contractor Aesica for £230m from Silverfleet Capital in a deal announced today.

Fraudsters who hoodwinked Medidata Solutions into transferring $4.8m to an "overseas" account this month did not access customer data says the clinical trial IT firm.

CRO PPD has exercised its option to acquire the remaining minority ownership interest of X-Chem for an undisclosed sum. X-Chem will continue to operate as a small molecule discovery company with its entire existing staff and management team. 

Global Industry News

Waiting on the US: Rapid biosimilar uptake worldwide stalling, report finds from BioPharma-Reporter.com

Chief among the potential drivers for the world’s biosimilar market is establishing a market in the US, which continues to stall, according to a new report.

Indian firm, 26 others cited for failing to pay GDUFA fees from in-PharmaTechnologist.com

Indian generic manufacturer Marck Biosciences has received a warning letter from the US FDA for failing to pay its annual facility fees for the past two years, which for foreign fixed-dose formulation facilities in 2014 was $235,152 .

DISPATCHES FOM TECHNOPHARM, NUREMBERG

MAb production driving continuous fermentation, says GEA from BioPharma-Reporter.com

Development of continuous fermentation has been driven by the increased production of monoclonal antibodies says GEA, with Asia-Pacific the new growth driver for such technologies.

Strides Arcolab to leverage API business in Shasun acquisition from in-PharmaTechnologist.com

The acquisition of Shasun Pharmaceuticals will add API production and contracting services to Strides Arcolab, and according to Shasun’s CEO no jobs will be lost.

'Worst addiction epidemic in US history' sparks call for Hamburg's resignation from in-PharmaTechnologist.com

An anti-addiction group has called for a change in leadership at the US FDA following the approval of Zohydro and other high-dose opioid analgesics.

Cell-culture flu vaccines shipped from Novartis plant for 2014-5 season from BioPharma-Reporter.com

Novartis has shipped the first of its cell-culture - rather than chicken egg - based vaccines for the 2014-2015 flu season from its North Carolina facility.

Patents and profits: the battle to own CRISPR from BioPharma-Reporter.com

CRISPR, the gene-editing technology that could revolutionise biologics, is set to become a patent battleground as companies vie over who owns the tool and its products, says an intellectual property expert.

Spotlight

Public CROs are sign of booming market, not PE apathy say experts
News focus

Public CROs are sign of booming market, not PE apathy say financial advisors

Experts have predicted more CROs will go public as Private Equity looks to get a return on...

Biologics trials: the ‘stretched’ global supply chain

Biologics trials: the ‘stretched’ global supply chain

The high cost and complexity of producing biopharmaceuticals for clinical trials limits supplies and makes effective logistics...

Charles River to lay off up to 30 employees following NCI contract end

Charles River to lay off up to 30 employees following NCI contract termination

Early phase CRO (contract research organization) Charles River Laboratories will lay off between 26 and 30 employees...

Pharma firms ‘saving billions’ in research – by giving away their tech

Pharma firms ‘saving billions’ in research – by giving away their tech

Pharma’s biggest players have donated more than $102m ($78m) of technology in a project to transform data...

CMO Kentucky Bioprocessing grows Ebola mAb from tobacco

CMO Kentucky Bioprocessing grows Ebola mAb from tobacco

ZMapp, the experimental Ebola therapy given to a handful of infected patients in West Africa, is being...

CRO Crown: Advancing in vitro models could benefit preclinical world

Crown Bio: New in vitro technology could revolutionise drug discovery

Increasing the predictivity of in vitro systems could cut the costs of drug development and shift preclinical...